ANIX vs EIX · rev $210.0K vs P/E 7.3, rev $17.60B
Anixa Biosciences Inc (ANIX) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Anixa Biosciences Inc (ANIX) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ANIX revenue for 2024-10-31 was $210.0K. Net income was -$12.7M. Revenue was up 0.0% from 2023-10-31 to 2024-10-31. ANIX currently screens at market cap $101.1M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ANIX currently screens at market cap $101.1M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ANIX and EIX stock pages for the full models.
Not investment advice.